Lipid and blood pressure reduction for reduction of cardiovascular mortality
Heinzl, S.
Medizinische Monatsschrift für Pharmazeuten 26(6): 185
2003
ISSN/ISBN: 0342-9601 PMID: 12840952 Document Number: 553188
Document emailed within 1 workday
Related Documents
Imai; Ohkubo; Sakuma; Tsuji; Satoh; Nagai; Hisamichi; Abe 1996: Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, northern Japan Blood Pressure Monitoring 1(3): 251-254Fagerberg, B.; Berglund, A.; Andersson, O.K.; Berglund, G. 1992: Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids Journal of Hypertension 10(9): 1053-1061
Gollapudi, A.K. 2008: Do lipid-lowering agents provide a greater reduction in cardiovascular events among patients with diabetes? Annals of Internal Medicine 149(11): 841; Author Reply 841-2
St Mary, E.W. 1978: Effective blood pressure reduction with metolazone Journal of the Florida Medical Association 65(10): 826-829
Januszewicz, Włodzimierz.; Januszewicz, A. 2004: Blood pressure reduction in hypertension--what is the optimal target value? Kardiologia Polska 61(11): 505-510
Edmonds, D.; Baumgart, P.; Tenschert, W.; Vetter, W.; Vetter, H. 1985: Verapamil 240 mg--effective blood pressure reduction by a single dose? Schweizerische Rundschau für Medizin Praxis 74(19): 507-509
Sokol, S.I.; Kapoor, J.R.; Foody, J.M. 2006: Blood pressure reduction in the primary and secondary prevention of stroke Current Vascular Pharmacology 4(2): 155-160
Mikunis, R.I.; Serkova, V.K.; Shirkova, T.A. 1976: Lipid metabolism and oxidation-reduction properties of blood in patients with arteriosclerotic myocardiosclerosis during treatment with lipoic acid Vrachebnoe Delo 3: 39-42
Waller, P.C.; Isles, C.G.; Lever, A.F.; Murray, G.D.; McInnes, G.T. 1988: Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease? Journal of Human Hypertension 2(1): 7-10
von Ardenne, M.; Reitnauer, P.G. 1982: Selective inhibition of microcirculation in tumor tissue by manipulated blood pressure reduction Archiv für Geschwulstforschung 52(5): 363-370
Chen, Y.; Wang, J.; An, Y.; Gong, Q.; He, Y.; Zhang, B.; Li, H.; Shuai, Y.; Tang, X.; Jiang, Y.; Hong, J.; Yang, W.; Hu, Y.; Li, G. 2015: Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study Zhonghua Nei Ke Za Zhi 54(1): 13-17
Simmen, R.; Greminger, P.; Lüscher, T.; Lüscher-Mutter, B.; Siegenthaler, W.; Vetter, W. 1984: Long-term effect of weight reduction in patients with hypertension and normal blood pressure Schweizerische Rundschau für Medizin Praxis 73(25): 799-804
Heermann, J. 1979: Flunitrazepam with anterograde amnesia and reduction of blood pressure before local anaesthesia without intubation in 3000 ENT operations Laryngologie Rhinologie Otologie 58(2): 162-164
Fujiwara, K.; Miasuda, R.; Takeda, S. 2011: Causative factors of esmolol-induced reduction in arterial blood pressure differ in accordance with its doses Masui. Japanese Journal of Anesthesiology 60(3): 353-360
Parati, G.; Mancia, G. 1999: Assessing effective and balanced twenty-four-hour blood pressure reduction by treatment: methodological aspects Journal of Hypertension 17(4): 455-456
Aoi, W.; Ueda, Y.; Tanigawa, M. 1992: Effect of weight loss on the reduction of blood pressure in obesity hypertension--hyperinsulinemia and renal sodium retention Nihon Jinzo Gakkai Shi 34(11): 1177-1182
Arvidsson, D.; Lindgren, S.; Almqvist, P.; Andersson, K.E.; Haglund, U. 1990: Role of the renin-angiotensin system in liver blood flow reduction produced by positive end-expiratory pressure ventilation Acta Chirurgica Scandinavica 156(5): 353-358
Jourdan, M. 2009: Casting light on harm reduction: introducing two instruments for analysing contradictions between harm reduction and 'non-harm reduction' International Journal on Drug Policy 20(6): 514-520
Jourdan, M. 2009: Casting light on harm reduction: introducing two instruments for analysing contradictions between harm reduction and 'non-harm reduction' International Journal on Drug Policy 20(6): 514-520
Edwards, K.D.; Bradley, S.E.; Herz, R. 1976: Blood pressure, cholesterol and triglyceride lowering effects of portacaval anastomosis. Efficacy in the rat, associated with hepatic weight reduction and cardiac and renal hypertrophy Medical Journal of Australia 1(13): 450-451